Engineering Cathepsin S Selective Chemical Probes and Antibody−Drug Conjugates through Substrate Profiling with Unnatural Amino Acids
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.6c00202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Maria Łęcka und 13 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland. Hauptthemen laut MEDLINE: Immunoconjugates, Cathepsins, Amino Acids, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre in Poland, Slovenian Research Agency.
Abstract (Originalsprache)
Cysteine cathepsins, particularly cathepsin S, regulate proteolytic signaling in cancer progression and immune modulation, yet selective tools for individual cathepsins remain limited. Here, we report the design of cathepsin S-selective probes and cathepsin S-cleavable antibody-drug conjugates (ADCs) using substrate profiling with unnatural amino acids. Hybrid Combinatorial Substrate Library (HyCoSuL) screening identified selective tetrapeptide motifs that were used to develop optimized fluorogenic substrates, irreversible inhibitors, and fluorescent activity-based probes with high selectivity for cathepsin S in biochemical and cellular assays. These peptide motifs were then incorporated as cleavable linkers in MMAE-based ADCs targeting HER-2 or TROP-2, enabling cathepsin S-dependent cytotoxicity across breast cancer models with distinct target-expression profiles. Finally, anti-cathepsin S antibodies combined with CyTOF analysis revealed the spatial distribution of cathepsin S and its coexpression with HER-2 and TROP-2 in breast cancer patient samples, suggesting that cathepsin S profiling may help inform future patient stratification strategies for cathepsin S-activated ADC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Chemistry, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland.
- Lower Silesian Oncology, Pulmonology and Hematology Center, 53-413 Wroclaw, Poland.
- Jozef Stefan Institute, 1000 Ljubljana,Slovenia.
- Faculty of Chemistry and Chemical Engineering, University of Ljubljana, 1000 Ljubljana,Slovenia.
- Centre for Chemical Biology, Institute of Physical Chemistry, Polish Academy of Sciences, 01-224 Warsaw, Poland.
- Department of Oncology, Faculty of Medicine, Wrocław Medical University, 50-367 Wroclaw.Poland.
ORCID-Profile: Piotr Jakimowicz, Boris Turk, Marcin Poręba
Förderung
- National Science Centre in Poland
- Slovenian Research Agency
Zitieren
APA
Łęcka, M., Gorzeń, O., Ćwilichowska-Puślecka, N., Nguyen, J., Majchrzak, M., Pippa, V., Jakimowicz, P., Wiśniewski, J., Dołęga-Kozierowski, B., Kasprzak, P., Turk, B., Drąg, M., Matkowski, R., & Poręba, M. (2026). Engineering Cathepsin S Selective Chemical Probes and Antibody−Drug Conjugates through Substrate Profiling with Unnatural Amino Acids. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c00202
Vancouver
Łęcka M, Gorzeń O, Ćwilichowska-Puślecka N, Nguyen J, Majchrzak M, Pippa V, et al. Engineering Cathepsin S Selective Chemical Probes and Antibody−Drug Conjugates through Substrate Profiling with Unnatural Amino Acids. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c00202
BibTeX
@article{cka2026,
author = {Łęcka, Maria and Gorzeń, Oliwia and Ćwilichowska-Puślecka, Natalia and Nguyen, Julia and Majchrzak, Martyna and Pippa, Vanessa and Jakimowicz, Piotr and Wiśniewski, Jerzy and Dołęga-Kozierowski, Bartosz and Kasprzak, Piotr and Turk, Boris and Drąg, Marcin and Matkowski, Rafał and Poręba, Marcin},
title = {Engineering Cathepsin S Selective Chemical Probes and Antibody−Drug Conjugates through Substrate Profiling with Unnatural Amino Acids},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c00202}
}
EUVIMED